Histamine human immunoglobulin (Guangdong Danxia Biopharm)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHistamine human immunoglobulin (Guangdong Danxia Biopharm)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsUrticariaAsthmaBronchitis, Chronic
Global Approved IndicationsUrticariaAsthmaBronchitis, Chronic
Approved Indications in ChinaUrticariaAsthmaBronchitis, Chronic
Original Approved Country/TerritoryMainland China
Original Approved Date2012/02/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGuangdong Danxia Biological Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGuangdong Danxia Biological Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsUrticariaAsthmaBronchitis, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeJ06BA01
Related LinksN/A